Financials in USD. Standardized financial statements.
A compact view of how Agilon Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B | $794.41M |
| Revenue Growth? | -2.1% | +40.4% | +80.7% | +57.0% | +24.9% | +53.4% | 0.0% |
| Cost of Revenue? | $6.12B | $6.06B | $4.25B | $2.28B | $1.46B | $1.12B | $765.90M |
| Gross Profit? | -$188.61M | $4.84M | $69.67M | $111.36M | $65.74M | $94.15M | $28.51M |
| Gross Margin? | -3.2% | +0.1% | +1.6% | +4.7% | +4.3% | +7.7% | +3.6% |
| Operating Expenses? | $232.46M | $296.97M | $301.80M | $216.74M | $437.99M | $150.82M | $135.09M |
| Operating Income? | -$421.08M | -$292.13M | -$232.13M | -$105.38M | -$372.24M | -$56.67M | -$106.57M |
| EBITDA? | -$368.86M | -$218.19M | -$167.64M | -$72.41M | -$362.16M | -$40.11M | -$64.21M |
| Income Before Tax | -$404.10M | -$248.83M | -$194.46M | -$90.67M | -$382.98M | -$62.34M | -$114.69M |
| Income Tax Expense | $1.25M | $1.45M | $791,000 | $1.64M | $886,000 | $865,000 | -$232,000 |
| Net Income? | -$405.35M | -$260.15M | -$262.60M | -$106.55M | -$406.49M | -$60.05M | -$282.59M |
| EPS? | $-24.50 | $-15.75 | $-16.00 | $-6.50 | $-27.25 | $-4.00 | $-18.50 |
| Diluted EPS? | $-24.50 | $-15.75 | $-16.00 | $-6.50 | $-27.25 | $-4.00 | $-18.50 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality